Clinical Trials on Castrate Sensitive Prostate Cancer in New Zealand
Total 1095 results
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Virginia...CompletedBreast Cancer | Lung Cancer | Prostate CancerUnited States
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
AmgenActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterCompletedHead and Neck Cancer | Prostate CancerUnited States
-
Eli Lilly and CompanyCompletedProstate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedStage I Breast Cancer | Stage II Breast Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer... and other conditionsUnited States
-
Prostate Cancer Clinical Trials ConsortiumUniversity of Chicago; Astellas Pharma IncTerminatedProstate CancerUnited States
-
Duke UniversityJohns Hopkins University; Memorial Sloan Kettering Cancer Center; Dana-Farber... and other collaboratorsCompletedProstate CancerUnited States
-
Bristol-Myers SquibbRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
PharmatechWatson Pharmaceuticals; Manyak, Michael, M.D.TerminatedProstate CancerUnited States
-
Lava TherapeuticsMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States, Spain, Netherlands
-
Peter MacCallum Cancer Centre, AustraliaUnited States Department of Defense; Advanced Accelerator Applications; Australian... and other collaboratorsActive, not recruitingMetastatic Hormone Naive Prostate CancerAustralia
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
NYU Langone HealthTerminatedProstate CancerUnited States
-
Maimonides Medical CenterWithdrawn
-
Roswell Park Cancer InstituteCompletedProstate CancerUnited States
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
Memorial Sloan Kettering Cancer CenterFordham UniversityCompleted
-
Oncternal Therapeutics, IncRecruitingMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States
-
University of Wisconsin, MadisonCompleted
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Lung Cancer | Prostate CancerUnited States
-
Novo Nordisk A/STerminated
-
Memorial Sloan Kettering Cancer CenterState University of New York - Downstate Medical Center; Kings County Hospital... and other collaboratorsCompleted
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteCompleted
-
University of New MexicoCompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteTerminatedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Terminated
-
Roswell Park Cancer InstituteTerminated
-
Francis Medical Inc.CompletedProstate CancerUnited States
-
Ceevra, Inc.Active, not recruiting
-
Yale UniversityNovartis; Genentech, Inc.TerminatedBreast Cancer | Hormone-Sensitive Breast CancerUnited States
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
Columbia UniversityWithdrawnProstate Cancer | Robotic Prostatectomy | Foley Catheter DiscomfortUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedMetastatic Castration-Resistant Prostate CancerBelgium, France, Germany, Spain, United Kingdom
-
National Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
NYU Langone HealthCompletedProstate Cancer | Bladder CancerUnited States
-
Xencor, Inc.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedProstate Cancer | Bladder CancerUnited States
-
Harpoon TherapeuticsTerminatedAdvanced Prostate CancerUnited States, United Kingdom
-
InSightecActive, not recruitingProstate CancerUnited States
-
SanofiCompletedProstate CancerFrance, United Kingdom, United States
-
PfizerAstellas Pharma IncActive, not recruiting